Clinical genomics of renal epithelial tumors.

[1]  Hereditary papillary renal cell carcinoma , 2020, Definitions.

[2]  P. Sathe,et al.  Xp11 translocation renal cell carcinoma. , 2013, Indian journal of pathology & microbiology.

[3]  雅州 坂口,et al.  [Von Hippel-Lindau disease]. , 2012 .

[4]  E. Jonasch,et al.  Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosis , 2011, Modern Pathology.

[5]  A. Zlotta,et al.  Altered transcription factor E3 expression in unclassified adult renal cell carcinoma indicates adverse pathological features and poor outcome , 2011, BJU international.

[6]  L. Lipton,et al.  Case report: renal cell carcinoma segregating with a t(2;3)(q37.3;q13.2) chromosomal translocation in an Ashkenazi Jewish family , 2011, Familial Cancer.

[7]  J. Bridge,et al.  Molecular diagnostics of soft tissue tumors. , 2011, Archives of pathology & laboratory medicine.

[8]  Yiping Shen,et al.  Next-generation sequencing strategies enable routine detection of balanced chromosome rearrangements for clinical diagnostics and genetic research. , 2011, American journal of human genetics.

[9]  L. Hoefsloot,et al.  Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis , 2011, Clinical genetics.

[10]  P. A. Futreal,et al.  Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma , 2010, Nature.

[11]  A. Byars,et al.  Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. , 2010, The New England journal of medicine.

[12]  E. Maher.  Genetics of Familial Renal Cancers , 2010, Nephron Experimental Nephrology.

[13]  A. Belldegrun,et al.  Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma , 2010, Cancer.

[14]  E. Mardis,et al.  Analysis of next-generation genomic data in cancer: accomplishments and challenges. , 2010, Human molecular genetics.

[15]  Jorge Oliveira,et al.  Feasibility of differential diagnosis of kidney tumors by comparative genomic hybridization of fine needle aspiration biopsies , 2010, Genes, chromosomes & cancer.

[16]  F. Burel-Vandenbos,et al.  Strength of molecular cytogenetic analyses for adjusting the diagnosis of renal cell carcinomas with both clear cells and papillary features: a study of three cases , 2010, Virchows Archiv.

[17]  K. Maclennan,et al.  Using next-generation sequencing for high resolution multiplex analysis of copy number variation from nanogram quantities of DNA from formalin-fixed paraffin-embedded specimens , 2010, Nucleic acids research.

[18]  D. de Jong,et al.  Hereditary causes of kidney tumours , 2010, European journal of clinical investigation.

[19]  Gyan Bhanot,et al.  Abstract 1996: Molecular stratification of clear cell renal cell carcinoma by consensus clustering reveals distinct subtypes and survival patterns , 2010 .

[20]  Kazuhisa Takahashi,et al.  Clinical and genetic spectrum of Birt–Hogg–Dubé syndrome patients in whom pneumothorax and/or multiple lung cysts are the presenting feature , 2010, Journal of Medical Genetics.

[21]  Z. Gatalica,et al.  Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases , 2010, Virchows Archiv.

[22]  C. Sternberg,et al.  Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  F. Monzon,et al.  Oncocytic Renal Neoplasms: A Molecular Approach to a Common Diagnostic Challenge , 2010 .

[24]  S. Richard,et al.  Birt-Hogg-Dubé syndrome: diagnosis and management. , 2009, The Lancet. Oncology.

[25]  W. Samlowski,et al.  Phase II study of erlotinib in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Gurpreet W. Tang,et al.  Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes , 2009, Nature.

[27]  L. Truong,et al.  Virtual-Karyotyping With SNP Microarrays in Morphologically Challenging Renal Cell Neoplasms: A Practical and Useful Diagnostic Modality , 2009, The American journal of surgical pathology.

[28]  A. Jauch,et al.  Trisomy 7 and 17 mark papillary renal cell tumours irrespectively of variation of the phenotype , 2009, Journal of Clinical Pathology.

[29]  A. Jauch,et al.  Three genetic developmental stages of papillary renal cell tumors: Duplication of chromosome 1q marks fatal progression , 2009, International journal of cancer.

[30]  Peter A Pinto,et al.  The clinical implications of the genetics of renal cell carcinoma. , 2009, Urologic oncology.

[31]  R. Figlin,et al.  Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies , 2009, Medical oncology.

[32]  A. Belldegrun,et al.  Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  R. Dhir,et al.  Virtual karyotyping with SNP microarrays reduces uncertainty in the diagnosis of renal epithelial tumors , 2008, Diagnostic pathology.

[34]  S. Richard,et al.  Familial Non-VHL Clear Cell (Conventional) Renal Cell Carcinoma: Clinical Features, Segregation Analysis, and Mutation Analysis of FLCN , 2008, Clinical Cancer Research.

[35]  C. Ricketts,et al.  Germline SDHB mutations and familial renal cell carcinoma. , 2008, Journal of the National Cancer Institute.

[36]  S. Hirohashi,et al.  Genetic Clustering of Clear Cell Renal Cell Carcinoma Based on Array-Comparative Genomic Hybridization: Its Association with DNA Methylation Alteration and Patient Outcome , 2008, Clinical Cancer Research.

[37]  P. Argani,et al.  Papillary Renal Cell Carcinoma With Low-grade Spindle Cell Foci: A Mimic of Mucinous Tubular and Spindle Cell Carcinoma , 2008, The American journal of surgical pathology.

[38]  B. Lane,et al.  Active surveillance of renal masses in elderly patients. , 2008, The Journal of urology.

[39]  R. Dhir,et al.  Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors , 2008, Modern Pathology.

[40]  S. Steinberg,et al.  BHD mutations, clinical and molecular genetic investigations of Birt–Hogg–Dubé syndrome: a new series of 50 families and a review of published reports , 2008, Journal of Medical Genetics.

[41]  Bohuslav Melichar,et al.  Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial , 2007, The Lancet.

[42]  H. Tagawa,et al.  High‐resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma , 2007, The Journal of pathology.

[43]  B Cochand-Priollet,et al.  Profiling and classification tree applied to renal epithelial tumours , 2007, Histopathology.

[44]  B. Delahunt,et al.  Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype , 2007, Pathology.

[45]  T. Lebret,et al.  Percutaneous core biopsy for renal masses: indications, accuracy and results. , 2007, The Journal of urology.

[46]  C. Korch,et al.  A constitutional balanced t(3;8)(p14;q24.1) translocation results in disruption of the TRC8 gene and predisposition to clear cell renal cell carcinoma , 2007, Genes, chromosomes & cancer.

[47]  Michael A S Jewett,et al.  Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. , 2007, The Journal of urology.

[48]  J. Oxley,et al.  Metastatic renal oncocytoma , 2007, Journal of Clinical Pathology.

[49]  S. Steinberg,et al.  Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dubé syndrome. , 2007, American journal of respiratory and critical care medicine.

[50]  B. Delahunt,et al.  Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma , 2007, Modern Pathology.

[51]  S. Jung,et al.  Mucinous tubular and spindle cell carcinoma of kidney is probably a variant of papillary renal cell carcinoma with spindle cell features. , 2007, Annals of diagnostic pathology.

[52]  W. Linehan,et al.  Mechanisms of Disease: hereditary leiomyomatosis and renal cell cancer—a distinct form of hereditary kidney cancer , 2007, Nature Clinical Practice Urology.

[53]  Apurva A Desai,et al.  Sorafenib in advanced clear-cell renal-cell carcinoma. , 2007, The New England journal of medicine.

[54]  R. Figlin,et al.  Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. , 2007, The New England journal of medicine.

[55]  R. Motzer,et al.  Treatment outcome for metastatic papillary renal cell carcinoma patients , 2006, Cancer.

[56]  B. Delahunt,et al.  Expanding the Histologic Spectrum of Mucinous Tubular and Spindle Cell Carcinoma of the Kidney , 2006, The American journal of surgical pathology.

[57]  M. Ladanyi,et al.  The evolving story of renal translocation carcinomas. , 2006, American journal of clinical pathology.

[58]  W. Linehan,et al.  Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer , 2006, Journal of Medical Genetics.

[59]  B. Delahunt,et al.  Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma , 2006, Modern Pathology.

[60]  C. Taylor,et al.  Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer. , 2006, Cancer research.

[61]  A. Svindland,et al.  Genomic aberrations in mucinous tubular and spindle cell renal cell carcinomas , 2006, Modern Pathology.

[62]  N. Rioux-Leclercq,et al.  Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  J. Srigley,et al.  Immunohistochemical Analysis of Mucinous Tubular and Spindle Cell Carcinoma and Papillary Renal Cell Carcinoma of the Kidney: Significant Immunophenotypic Overlap Warrants Diagnostic Caution , 2006, The American journal of surgical pathology.

[64]  L. Aaltonen,et al.  Increased risk of cancer in patients with fumarate hydratase germline mutation , 2005, Journal of Medical Genetics.

[65]  P. Choyke,et al.  Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer , 2005, Journal of Medical Genetics.

[66]  J. Lam,et al.  Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. , 2005, The Journal of urology.

[67]  P. Tamboli,et al.  Oncocytic renal neoplasms: diagnostic considerations. , 2005, Clinics in laboratory medicine.

[68]  Liang Cheng,et al.  Application of molecular diagnostic techniques to renal epithelial neoplasms. , 2005, Clinics in laboratory medicine.

[69]  K. Mrózek,et al.  Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas. , 2005, Oncology reports.

[70]  Yuen-Li Chung,et al.  HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. , 2005, Cancer cell.

[71]  R Y Ball,et al.  Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs , 2005 .

[72]  A. Bernheim,et al.  Characterization of quantitative chromosomal abnormalities in renal cell carcinomas by interphase four-color fluorescence in situ hybridization. , 2005, Cancer genetics and cytogenetics.

[73]  B. Delahunt,et al.  Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma , 2005, Modern Pathology.

[74]  I. Sesterhenn,et al.  World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .

[75]  W. Kaelin,et al.  Role of VHL gene mutation in human cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[76]  S. Jung,et al.  Renal cell carcinoma in South Korea: a multicenter study. , 2004, Human pathology.

[77]  W. Marston Linehan,et al.  Genetic Basis of Cancer of the Kidney , 2004, Clinical Cancer Research.

[78]  C. Eng,et al.  Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. , 2004, JAMA.

[79]  J. Testa,et al.  The genetics of renal oncocytosis: a possible model for neoplastic progression. , 2004, Cancer genetics and cytogenetics.

[80]  P. Choyke,et al.  Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. , 2003, American journal of human genetics.

[81]  P. Tamboli,et al.  Impact of Histologic Subtyping of Renal Epithelial Neoplasms: Authors' Reply , 2003 .

[82]  M. Ladanyi,et al.  PRCC-TFE3 Renal Carcinomas: Morphologic, Immunohistochemical, Ultrastructural, and Molecular Analysis of an Entity Associated With the t(X;1)(p11.2;q21) , 2002, The American journal of surgical pathology.

[83]  C. Rakozy,et al.  Low-Grade Tubular-Mucinous Renal Neoplasms: Morphologic, Immunohistochemical, and Genetic Features , 2002, Modern Pathology.

[84]  G. Martens,et al.  Understanding familial and non-familial renal cell cancer. , 2002, Human molecular genetics.

[85]  Maria Merino,et al.  Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. , 2002, Cancer cell.

[86]  A. Paetau,et al.  Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer , 2002, Nature Genetics.

[87]  Mahul B. Amin,et al.  Prognostic Impact of Histologic Subtyping of Adult Renal Epithelial Neoplasms: An Experience of 405 Cases , 2002, The American journal of surgical pathology.

[88]  Ajay N. Jain,et al.  Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. , 2002, Cancer research.

[89]  N. Masumori,et al.  Recurrence of renal cell carcinoma more than 5 years after nephrectomy , 2002, International journal of urology : official journal of the Japanese Urological Association.

[90]  A. V. van Kessel,et al.  Impairment of MAD2B–PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[91]  A. Poustka,et al.  Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis. , 2001, Cancer research.

[92]  A. Hartmann,et al.  Familial and Sporadic Renal Oncocytomas – A Comparative Molecular–Genetic Analysis , 2001, European Urology.

[93]  D. Evans,et al.  Germline SDHD mutation in familial phaeochromocytoma , 2001, The Lancet.

[94]  M. Rubin,et al.  Renal oncocytosis: a morphologic study of fourteen cases. , 1999, The American journal of surgical pathology.

[95]  H. Moch,et al.  Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes. , 1998, The American journal of pathology.

[96]  S Povey,et al.  Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. , 1997, Science.

[97]  E. van den Berg,et al.  Cytogenetic classification of renal cell cancer. , 1997, Cancer genetics and cytogenetics.

[98]  S. Scherer,et al.  Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas , 1997, Nature Genetics.

[99]  P. Bugert,et al.  Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis. , 1996, The American journal of pathology.

[100]  G. Krinsky,et al.  Small renal parenchymal neoplasms: further observations on growth. , 1995, Radiology.

[101]  S. Bonsib,et al.  Papillary renal tumors. Morphologic, cytochemical, and genotypic features , 1995, Cancer.

[102]  S. Thomas,et al.  Identification and characterization of the tuberous sclerosis gene on chromosome 16 , 1993, Cell.

[103]  J. Gnarra,et al.  Identification of the von Hippel-Lindau disease tumor suppressor gene. , 1993, Science.

[104]  G. Kovacs,et al.  Cytogenetics of papillary renal cell tumors , 1991, Genes, chromosomes & cancer.

[105]  von Hippel-Lindau disease , 1991, The Lancet.

[106]  J. Rubin,et al.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. , 1991, Science.

[107]  W. Gunn.  Cancer: Principles and Practice of Oncology , 1982 .

[108]  W. J. Dubé,et al.  Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. , 1977, Archives of dermatology.

[109]  J. Stockman,et al.  Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis , 2012 .

[110]  Gudrun Schleiermacher,et al.  Transcription factor E3 and transcription factor EB renal cell carcinomas: clinical features, biological behavior and prognostic factors. , 2011, The Journal of urology.

[111]  R. Montironi,et al.  Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms. , 2009, Human pathology.

[112]  W. Linehan,et al.  Unique Opportunity for Disease-based Therapy* , 2009 .

[113]  Liang Cheng,et al.  Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma , 2008, Modern Pathology.

[114]  L. Aaltonen,et al.  Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. , 2004, American journal of human genetics.

[115]  O. Iliopoulos.  von Hippel-Lindau disease: genetic and clinical observations. , 2001, Frontiers of hormone research.

[116]  W. Linehan,et al.  Improved detection of germline mutations in the von Hippel‐Lindau disease tumor suppressor gene , 1998, Human mutation.

[117]  F. Waldman,et al.  Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. , 1996, Cancer research.

[118]  E. Schröck,et al.  Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. , 1994, The American journal of pathology.

[119]  M. Karno,et al.  Renal cell carcinoma. , 1956, Bulletin. Tufts-New England Medical Center.